Navigation Links
Winner Medical Receives European Patent Office Approval for PurCotton(TM) Production Method
Date:2/27/2009

SHENZHEN, China, Feb. 27 /PRNewswire-Asia/ -- Winner Medical Group Inc. (OTC Bulletin Board: WMDG; "Winner Medical", the "Company"), a leading manufacturer in the Chinese medical dressing industry (medical and wound care products), today announced that the European Patent Office has decided to grant the patent for producing PurCotton(TM) products to Winner Medical. The following are specifically covered by the patent: method for producing spunlace non-woven cloth, method for producing spunlace non-woven cloth with X-ray detectable element and spunlace non-woven cloth with X-ray detectable element produced thereby.

Mr. Jianquan Li, CEO of Winner Medical, remarked, "This means the achievement of another important milestone. The European patent enables us to plan on a long-term basis and to advance the market entry for our PurCotton(TM) products steadily. Now we have valid national rights in approximately 34 member states of the European Patent Office."

As of February 2009, Winner Medical has obtained patents for PurCotton(TM) products in several countries, including China, the U.S.A., Russia, Singapore, South Africa, and 34 member states of the European Patent Office. The patent application is also pending in other regions such as Japan, South America, India and the Middle East.

PurCotton(TM) products combine the superior characteristics of both natural cotton and materials made using nonwoven technology. It has many advantages over both woven cotton and synthetic nonwoven fabric, as it is of high quality, natural, safe, strong, durable, healthy and environmentally-friendly. Winner Medical's patented manufacturing process enables the Company to produce PurCotton(TM) at a lower cost than the woven cotton products, and it can therefore offer customers a lower price without sacrificing its margin. The Company expects the new PurCotton(TM) products to be a medium to long term growth contributor to its revenue.

About Winner Medical

Winner Medical is a leading manufacturer in the medical dressing industry (medical and wound care products) in China. Headquartered in Shenzhen, the Company has eight wholly-owned manufacturing and distribution facilities, four joint-venture factories and over 5,000 employees. The Company engages in the manufacture, sale, research, and development of medical care products, wound care products, home care products and PurCotton(TM) products, a nonwoven fabric made from 100% natural cotton. The products are sold worldwide, with Europe, the U.S. and Japan serving as the top three markets. The Company currently holds 50 patents and patent applications in various products and manufacturing processes and is one of the few Chinese companies licensed with the U.S. Food and Drug Administration (FDA) to ship finished, sterilized products directly to the U.S. market. To learn more about Winner Medical, visit Winner Medical's web site http://www.winnermedical.com .

Forward-Looking Statements

This press release contains certain statements that may include "forward looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements, other than statements of historical fact included herein are "forward-looking statements" including statements regarding Winner Medical and its subsidiary companies' business strategy, plans and objective and statements of non-historical information. These forward looking statements are often identified by the use of forward-looking terminology such as "believes," "expects" or similar expressions, involve known and unknown risks and uncertainties. Although Winner Medical believes that the expectations reflected in these forward-looking statements are reasonable, they do involve assumptions, risks and uncertainties, and these expectations may prove to be incorrect. You should not place undue reliance on these forward-looking statements, which speak only as of the date of this press release. Winner Medical's actual results could differ materially from those anticipated in these forward-looking statements as a result of a variety of factors, including those discussed in Winner Medical's periodic reports that are filed with and available from the Securities and Exchange Commission. All forward- looking statements attributable to Winner Medical or persons acting on its behalf are expressly qualified in their entirety by these factors. Other than as required under the securities laws, Winner Medical does not assume a duty to update these forward-looking statements.

    For more information, please contact:

    Investor Relations Contacts:
     Peng Zhai
     Assistant Manager, Investor Relations
     Winner Medical Group Inc.
     Tel:   +86-755-2806-6858
     Email: peng.zhai@winnermedical.com

'/>"/>
SOURCE Winner Medical Group Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. AMERIGROUP Foundation and Union City Board of Education Announce Winners of Word About Health Contest
2. Great Comebacks(R) Program Announces 2008 National Award Winner and Inaugural Tony Snow Public Service Award
3. Case Western Reserve University faculty named 2009 NorTech Innovation Award winner
4. NorTech, Crains Cleveland Business Honor 2009 Innovation Award Winners
5. Womens Healthcare Associates Midwife Winner of American Academy of Nurse Practitioners State Award of Excellence
6. Winner Medical Reports First Quarter Fiscal 2009 Results
7. California Veterinarian Wins Americas Best Vet Honor; Four Regional Winners Also Named
8. Winner Medical Schedules 2008/2009 First Quarter Earnings Release on Friday, February 13, 2009
9. Nobel Peace Prize Winner Stephen Schneider Keynotes Annual Conference of Community Oncologists
10. ING and Fit Miami Foundation Name Winners of ING Run For Something Better Student Essay Contest
11. Sharing Miracles Television Program to Feature Country Music Superstar and Grammy Winner Naomi Judd
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Long Beach, CA (PRWEB) , ... June 25, 2016 , ... ... from UCLA with Magna Cum Laude and his M.D from the David Geffen School ... San Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, Van Mitchell, ... at Work award to iHire in recognition of their exemplary accomplishments in worksite health ... annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , Belgium , June ... MKT: VNRX), today announced the appointment of Dr. ... of Directors as a Non-Executive Director, effective June ... Company,s Audit, Compensation and Nominations and Governance Committees.  ... Dr. Futcher will provide independent expertise and strategic ...
(Date:6/23/2016)... June 23, 2016 Research and ... Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), ... Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is projected ... CAGR of 6.1% in the forecast period 2016 to ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
Breaking Medicine Technology: